8-K Featured Impact 6/10 Corporate Governance

$OSCR · Oscar Health, Inc.

November 16, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Oscar Health filed an 8-K reporting Item 5.02 board changes. On November 12, 2026, the board appointed Tomer Cohen (former LinkedIn CPO), Eric Larsen (TowerBrook Advisors President, Thrive Capital senior advisor), and Rajat Taneja (Visa President of Technology) as directors effective November 13, 2026, increasing board size from eight to eleven. Cohen joined the Compensation Committee; Taneja joined the Audit and NCG Committees. All three were deemed independent under NYSE rules and will receive standard non-employee director compensation, including a $70,000 annual cash retainer and $200,000 initial RSU grant.

  • Board expanded from eight to eleven directors effective November 13, 2026.
  • Tomer Cohen, former LinkedIn Chief Product Officer (2020-2026), joins the Compensation Committee.
  • Rajat Taneja, Visa's President of Technology since 2019, joins the Audit and NCG Committees.
  • Eric Larsen is a senior advisor to Thrive Capital, Oscar Health's majority stockholder.
  • Each new director receives a $70,000 annual cash retainer and $200,000 initial RSU grant.

Markets closed — no regular-session reaction yet; extended-hours move not captured here.

Oscar Health is loading its board with AI and technology talent, signaling a strategic push toward tech-driven healthcare.

Health insurers are adding AI and technology expertise to boards as digital-first care models gain prominence.

Larsen's role as senior advisor to Thrive Capital, the majority stockholder, could raise governance independence questions despite NYSE independence determination.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →